Liste d'obligations internationales ( Toutes )
Société émettrice | Code ISIN | Devise | Coupon | Montant minimal | Maturité | Prix sur le marché | |
AbbVie Inc. | US00287YBD04 | USD | 4.875% | 2 000 USD | 13/11/2048 | 91.138 | |
AbbVie Inc. | XS1520907814 | EUR | 2.125% | 100 000 EUR | 17/11/2028 | 100 | |
AbbVie Inc. | US00287YAG44 | USD | 1.2% | 06/11/2015 | Echue | ||
AbbVie Inc. | USU0029QAV87 | USD | 3.2% | 2 000 USD | 21/11/2029 | 90.471 | |
AbbVie Inc. | USU0029QAN61 | USD | 2.3% | 2 000 USD | 21/11/2022 | Echue | |
AbbVie Inc. | USU0029QAQ92 | USD | 2.6% | 2 000 USD | 21/11/2024 | Echue | |
AbbVie Inc. | US00287YAU38 | USD | 2.3% | 2 000 USD | 13/05/2021 | Echue | |
AbbVie Inc. | US00287YAQ26 | USD | 3.6% | 2 000 USD | 13/05/2025 | Echue | |
AbbVie Inc. | US00287YAR09 | USD | 4.5% | 2 000 USD | 13/05/2035 | 100 | |
AbbVie Inc. | US00287YAS81 | USD | 4.7% | 2 000 USD | 14/05/2045 | 100 | |
AbbVie Inc. | US00287YAP43 | USD | 3.2% | 2 000 USD | 05/11/2022 | Echue | |
AbbVie Inc. | US00287YAL39 | USD | 2.9% | 2 000 USD | 05/11/2022 | Echue | |
AbbVie Inc. | US00287YAX76 | USD | 2.85% | 2 000 USD | 13/05/2023 | Echue | |
AbbVie Inc. | US00287YBC21 | USD | 3.75% | 2 000 USD | 13/11/2023 | Echue | |
AbbVie Inc. | US00287YAV11 | USD | 4.3% | 2 000 USD | 13/05/2036 | 100 | |
AbbVie Inc. | US00287YBE86 | USD | 3.375% | 2 000 USD | 13/11/2021 | Echue | |
AbbVie Inc. | US00287YBF51 | USD | 4.25% | 2 000 USD | 13/11/2028 | 100.841 | |
AbbVie Inc. | XS2055646918 | EUR | 0.75% | 100 000 EUR | 17/11/2027 | 100 | |
AbbVie Inc. | USU0029QAL06 | USD | 2.15% | 2 000 USD | 18/11/2021 | Echue | |
AbbVie Inc. | USU0029QAP10 | USD | 2.346% | 2 000 USD | 20/11/2022 | Echue | |
AbbVie Inc. | USU0029QAM88 | USD | 2.153% | 2 000 USD | 18/11/2021 | Echue | |
AbbVie Inc. | USU0029QAU05 | USD | 2.95% | 2 000 USD | 20/11/2026 | 100 | |
AbbVie Inc. | USU0029QAR75 | USD | 4.05% | 2 000 USD | 20/11/2039 | Echue | |
AbbVie Inc. | USU0029QAT32 | USD | 2.046% | 2 000 USD | 20/05/2021 | Echue | |
AbbVie Inc. | USU0029QAS58 | USD | 4.25% | 2 000 USD | 20/11/2049 | 100 | |
AbbVie Inc. | US00287YAT64 | USD | 2.5% | 2 000 USD | 14/05/2020 | Echue | |
AbbVie Inc. | US00287YAN94 | USD | 1.8% | 2 000 USD | 14/05/2018 | Echue | |
AbbVie Inc. | USU0029QBC97 | USD | 3.85% | 2 000 USD | 14/06/2024 | Echue | |
AbbVie Inc. | USU0029QAY27 | USD | 5% | 2 000 USD | 14/12/2021 | Echue | |
AbbVie Inc. | USU0029QAZ91 | USD | 3.45% | 2 000 USD | 15/03/2022 | Echue | |
AbbVie Inc. | USU0029QBA32 | USD | 3.25% | 2 000 USD | 01/10/2022 | Echue | |
AbbVie Inc. | USU0029QBB15 | USD | 2.8% | 2 000 USD | 14/03/2023 | Echue | |
AbbVie Inc. | US00287YBR99 | USD | 4.05% | 2 000 USD | 20/11/2039 | 100 | |
AbbVie Inc. | US00287YBQ17 | USD | 2.6% | 2 000 USD | 20/11/2024 | Echue | |
AbbVie Inc. | US00287YBT55 | USD | 0.597% | 2 000 USD | 20/05/2021 | Echue | |
AbbVie Inc. | US00287YBS72 | USD | 4.25% | 2 000 USD | 20/11/2049 | 68.189 | |
AbbVie Inc. | US00287YBN85 | USD | 0.897% | 2 000 USD | 20/11/2022 | Echue | |
AbbVie Inc. | US00287YBW84 | USD | 3.2% | 2 000 USD | 20/11/2029 | 91.466 | |
AbbVie Inc. | US00287YBL20 | USD | 2.3% | 2 000 USD | 20/11/2022 | Echue | |
AbbVie Inc. | US00287YBJ73 | USD | 0.691% | 2 000 USD | 18/11/2021 | Echue | |
AbbVie Inc. | US00287YBG35 | USD | 2.15% | 2 000 USD | 18/11/2021 | Echue | |
AbbVie Inc. | US00287YAA73 | USD | 1.2% | 2 000 USD | 06/11/2015 | Echue | |
AbbVie Inc. | US00287YDC03 | USD | 3.8% | 2 000 USD | 15/03/2025 | Echue | |
AbbVie Inc. | US00287YBX67 | USD | 3.2% | 2 000 USD | 20/11/2029 | 96.179 | |
AbbVie Inc. | US00287YCB39 | USD | 4.25% | 2 000 USD | 20/11/2049 | 80.982 | |
AbbVie Inc. | US00287YBV02 | USD | 2.95% | 2 000 USD | 20/11/2026 | 100 | |
AbbVie Inc. | US00287YCZ07 | USD | 4.625% | 2 000 USD | 30/09/2042 | 87.836 | |
AbbVie Inc. | US00287YCS63 | USD | 3.45% | 2 000 USD | 14/03/2022 | Echue | |
AbbVie Inc. | US00287YDB20 | USD | 4.75% | 2 000 USD | 14/03/2045 | 100 | |
AbbVie Inc. | US00287YCT47 | USD | 3.25% | 2 000 USD | 30/09/2022 | Echue | |
AbbVie Inc. | US00287YCU10 | USD | 2.8% | 2 000 USD | 14/03/2023 | Echue | |
AbbVie Inc. | US00287YCR80 | USD | 5% | 2 000 USD | 14/12/2021 | Echue | |
AbbVie Inc. | US00287YBM03 | USD | 2.3% | 2 000 USD | 20/11/2022 | Echue | |
AbbVie Inc. | US00287YBK47 | USD | 0.691% | 2 000 USD | 21/09/2050 | Echue | |
AbbVie Inc. | XS1520897163 | EUR | 0.375% | 100 000 EUR | 18/11/2019 | Echue | |
AbbVie Inc. | XS1520899532 | EUR | 1.375% | 100 000 EUR | 17/05/2024 | Echue | |
AbbVie Inc. | US00287YCY32 | USD | 4.55% | 2 000 USD | 15/03/2035 | 97.748 | |
AbbVie Inc. | USU0029QAD89 | USD | 4.4% | 2 000 USD | 06/11/2042 | 100 | |
AbbVie Inc. | XS2117754833 | EUR | 1.25% | 100 000 EUR | 31/05/2024 | Echue | |
AbbVie Inc. | XS2117753603 | EUR | 0% | 100 000 EUR | 15/11/2020 | Echue | |
AbbVie Inc. | US00287YAF60 | USD | 2% | 05/11/2018 | Echue | ||
AbbVie Inc. | XS2125914593 | EUR | 1.25% | 100 000 EUR | 31/05/2024 | Echue | |
AbbVie Inc. | USU0029QAX44 | USD | 4.875% | 2 000 USD | 15/02/2021 | Echue | |
AbbVie Inc. | US00287YBY41 | USD | 0% | 2 000 USD | 21/05/2021 | Echue | |
AbbVie Inc. | US00287YAK55 | USD | 2% | 1 000 USD | 06/11/2018 | Echue | |
AbbVie Inc. | XS2125913603 | EUR | 0.5% | 100 000 EUR | 01/06/2021 | Echue | |
AbbVie Inc. | US00287YBH18 | USD | 2.15% | 2 000 USD | 19/11/2021 | Echue | |
AbbVie Inc. | USU0029QAA41 | USD | 1.2% | 2 000 USD | 06/11/2015 | Echue | |
AbbVie Inc. | US00287YAH27 | USD | 0% | 2 000 USD | 06/11/2015 | Echue | |
AbbVie Inc. | US00287YAJ82 | USD | 1.75% | 2 000 USD | 06/11/2017 | Echue | |
AbbVie Inc. | XS2117754163 | EUR | 0.5% | 100 000 EUR | 01/06/2021 | Echue | |
AbbVie Inc. | USU0029QAB24 | USD | 1.75% | 2 000 USD | 06/11/2017 | Echue | |
AbbVie Inc. | USU0029QBE53 | USD | 4.625% | 2 000 USD | 01/10/2042 | Echue | |
AbbVie Inc. | XS2117754593 | EUR | 1.5% | 100 000 EUR | 14/11/2023 | Echue | |
AbbVie Inc. | USU0029QBG02 | USD | 4.75% | 2 000 USD | 15/03/2045 | 126.763 | |
AbbVie Inc. | US00287YBP34 | USD | 0% | 2 000 USD | 21/11/2022 | Echue | |
AbbVie Inc. | US00287YBZ16 | USD | 2.6% | 2 000 USD | 21/11/2024 | Echue | |
AbbVie Inc. | US00287YCX58 | USD | 3.8% | 2 000 USD | 15/03/2025 | Echue | |
AbbVie Inc. | USU0029QBD70 | USD | 4.55% | 2 000 USD | 15/03/2035 | 123.737 | |
AbbVie Inc. | XS2117755053 | EUR | 2.625% | 100 000 EUR | 15/11/2028 | 100 | |
AbbVie Inc. | XS2117755566 | EUR | 2.125% | 100 000 EUR | 01/06/2029 | 100 | |
AbbVie Inc. | XS2125913942 | EUR | 1.5% | 100 000 EUR | 15/11/2023 | Echue | |
AbbVie Inc. | XS2125914833 | EUR | 2.625% | 100 000 EUR | 15/11/2028 | 100 | |
AbbVie Inc. | US00287YDA47 | USD | 4.85% | 2 000 USD | 15/06/2044 | 100 | |
AbbVie Inc. | USU0029QBF29 | USD | 4.85% | 2 000 USD | 15/06/2044 | 128.708 | |
AbbVie Inc. | US00287YCG26 | USD | 3.25% | 2 000 USD | 01/10/2022 | Echue | |
AbbVie Inc. | US00287YAC30 | USD | 2.9% | 2 000 USD | 05/11/2022 | Echue | |
AbbVie Inc. | US00287YCH09 | USD | 2.8% | 2 000 USD | 14/03/2023 | Echue | |
AbbVie Inc. | US00287YCV92 | USD | 3.85% | 2 000 USD | 15/06/2024 | Echue | |
AbbVie Inc. | US00287YBU29 | USD | 2.95% | 2 000 USD | 20/11/2026 | 90.125 | |
AbbVie Inc. | XS2055647213 | EUR | 1.25% | 17/11/2031 | 90.46 | ||
AbbVie Inc. | XS2125914916 | EUR | 2.125% | 31/05/2029 | 97.94 | ||
AbbVie Inc. | USU0029QAC07 | USD | 2.9% | 06/11/2022 | Echue | ||
AbbVie Inc. | US00287YCA55 | USD | 4.05% | 2 000 USD | 20/11/2039 | 90.703 | |
AbbVie Inc. | US00287YAW93 | USD | 4.45% | 13/05/2046 | 87.037 | ||
AbbVie Inc. | US00287YAM12 | USD | 4.4% | 05/11/2042 | 91.266 | ||
AbbVie Inc. | US00287YDT38 | USD | 4.95% | 2 000 USD | 15/03/2031 | 103.037 | |
AbbVie Inc. | US00287YDW66 | USD | 5.4% | 2 000 USD | 15/03/2054 | 97.42 | |
AbbVie Inc. | US00287YDV83 | USD | 5.35% | 2 000 USD | 15/03/2044 | 96.773 | |
AbbVie Inc. | US00287YAY59 | USD | 3.2% | 13/05/2026 | 99.466 | ||
AbbVie Inc. | XS2117754916 | EUR | 1.25% | 100 000 EUR | 01/06/2024 | Echue | |
AbbVie Inc. | US00287YDX40 | USD | 5.5% | 15/03/2064 | 95.044 |
AbbVie is a research-based biopharmaceutical company focused on developing and marketing innovative therapies in several key therapeutic areas including immunology, oncology, neuroscience, and ophthalmology.
AbbVie est une société biopharmaceutique mondiale développant et commercialisant des médicaments innovants dans les domaines de l'immunologie, de l'oncologie, des maladies neurologiques et des soins spécialisés.
AbbVie è una società biofarmaceutica globale che si concentra sullo sviluppo e la commercializzazione di farmaci innovativi in aree terapeutiche quali l'immunologia, l'oncologia, le malattie neurologiche e le malattie infettive.